Amiyotrofik Lateral Skleroz Tanısında ve Tedavisinde Güncel Gelişmeler
Referanslar
Blacher E, Bashiardes S, Shapiro H, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474-480. doi:10.1038/s41586-019-1443-5
Niccolai E, Di Pilato V, Nannini G, et al. The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?. Biomedicines. 2021;9(7):753. doi:10.3390/biomedicines9070753
Brooks BR, Miller RG, Swash M, et al. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders. 2000;1(5):293-299. doi:10.1080/146608200300079536
Shefner JM, Al-Chalabi A, Baker MR, et al. A proposal for new diagnostic criteria for ALS. Clinical Neurophysioogyl. 2020;131(8):1975-1978. doi:10.1016/j.clinph.2020.04.005.
Hannaford A, Pavey N, van den Bos M, et al. Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis. Annals of neurology. 2021;89(5):979-986. doi:10.1002/ana.26045
Shen D, Yang X, Wang Y, et al. The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population. Translational neurodegeneration. 2021;10(1):28. doi:10.1186/s40035-021-00253-2
Rowland LP. Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve. 2010;41(2):161-165. doi:10.1002/mus.21565
Gordon PH, Cheng B, Katz IB, et al. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology. 2009;72(22):1948-1952. doi:10.1212/WNL.0b013e3181a8269b
Schito P, Ceccardi G, Calvo A, et al. Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study. Journal of neurology, neurosurgery, and psychiatry. 2020;91(9):1001-1003. doi:10.1136/jnnp-2020-323542
Malin JP, Poburski R, Reusche E. Clinical variants of amyotrophic lateral sclerosis: hemiplegic type of ALS and Mills syndrome. A critical review. Fortschritte der Neurologie-Psychiatrie. 1986;54(4):101-105. doi:10.1055/s-2007-1001856
Chiò A, Moglia C, Canosa A, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93(10):e984-e994. doi:10.1212/WNL.0000000000008063)
Watanabe Y, Raaphorst J, Izumi Y, et al. Cognitive and behavioral status in Japanese ALS patients: a multicenter study. Journal of neurology. 2020;267(5):1321-1330. doi:10.1007/s00415-019-09655-9
Pradat PF, Bruneteau G, Munerati E, et al. Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Movement Disorders. 2009;24(14):2143-2148. doi:10.1002/mds.22762
Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. Journal of neurology, neurosurgery, and psychiatry. 1999;67(2):214-216. doi:10.1136/jnnp.67.2.214
Piccione EA, Sletten DM, Staff NP, et al. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51(5):676-679. doi:10.1002/mus.24457
Rubio MA, Herrando-Grabulosa M, Navarro X. Sensory Involvement in Amyotrophic Lateral Sclerosis. International journal of molecular sciences. 2022;23(24):15521. doi:10.3390/ijms232415521
Johnson SA, Fang T, De Marchi F, et al. Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents. Drugs. 2022;82(13):1367-1388. doi:10.1007/s40265-022-01769-1
Aschenbrenner DS. New Drug Approved For ALS. The American journal of nursing. 2023;123(1):22-23. doi:10.1097/01.NAJ.0000911516.31267.67
Paganoni S, Macklin EA, Hendrix S, et al. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. The New England journal of medicine. 2020;383(10):919-930. doi:10.1056/NEJMoa1916945
Chiò A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurology. 2017;16(2):144-157. doi:10.1016/S1474-4422(16)30358-1
Kwak S. Pain in amyotrophic lateral sclerosis: a narrative review. Journal of Yeungnam medical science. 2022;39(3):181-189. doi:10.12701/jyms.2022.00332